Literature DB >> 10220282

Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists.

I S Lee1, K Y Jung, S R Oh, S H Park, K S Ahn, H K Lee.   

Abstract

We studied the structure-activity relationships of lignans from Schisandra chinensis and their derivatives as platelet activating factor (PAF) antagonists. Strong activity was shown in lignans without an ester group at C-6, a hydroxyl group at C-7 or a methylene dioxy moiety and with an R-biphenyl configuration. 6(7)-Dehydroschisandrol A, a derivative of schisandrol A, showed the highest activity (IC50, 2.1x10(-6) M) in this study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220282     DOI: 10.1248/bpb.22.265

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Schizandrol A: a lignan from Schisandra chinensis.

Authors:  Liang Zhao; Xiaoling Yu; Chungang Chen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-07-16

Review 2.  Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity.

Authors:  Alexander Panossian; Georg Wikman
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-19

Review 3.  Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies.

Authors:  Agnieszka Szopa; Radosław Ekiert; Halina Ekiert
Journal:  Phytochem Rev       Date:  2016-05-12       Impact factor: 5.374

Review 4.  Antioxidant Effects of Schisandra chinensis Fruits and Their Active Constituents.

Authors:  Dalia M Kopustinskiene; Jurga Bernatoniene
Journal:  Antioxidants (Basel)       Date:  2021-04-18

5.  Schisandra chinensis peptidoglycan-assisted transmembrane transport of lignans uniquely altered the pharmacokinetic and pharmacodynamic mechanisms in human HepG2 cell model.

Authors:  Charng-Cherng Chyau; Yaw-Bee Ker; Chi-Huang Chang; Shiau-Huei Huang; Hui-Er Wang; Chiung-Chi Peng; Robert Y Peng
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.